Amy Ware: Can a New Payer Model Transform Access to Cancer Treatment?

Coverage, in order

1. 12h ago
   
   OncoDaily obscure

   Amy Ware: Can a New Payer Model Transform Access to Cancer Treatment?

   Amy Ware, Principal Consultant at OncoEdge Advisory Partners, shared on LinkedIn: “Today, Humana, Evolent, and American Oncology Network announced an oncology model that removes traditional prior authorization for most anticancer

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.